Skip to main content
Top
Published in: Journal of the International AIDS Society 4/2010

Open Access 01-12-2010 | Oral presentation

0222. Major issues and their solutions in the management of HIV and TB — from the laboratory to the patient and population

Author: M Schechter

Published in: Journal of the International AIDS Society | Special Issue 4/2010

Login to get access

Excerpt

HIV is the strongest known risk factor for developing active tuberculosis. In individuals with Mycobacterium tuberculosis infection, the risk of developing active disease is 20 or more times greater in persons living with HIV than HIV negatives. Tuberculosis is the most common HIV-associated illness in resource poor settings and the most common opportunistic infection in patients receiving HAART in developed countries. Of the 33 million people estimated to be living with HIV globally in 2008, approximately 1.5 million were also tuberculosis patients. In that same year, tuberculosis was responsible for 25% of all deaths in HIV-infected individuals. Given the synergistic consequences of the two epidemics, has recommended several collaborative activities as part of core HIV and TB prevention, care and treatment services. In this conference, some of the most important recent advances in prevention, diagnosis, and treatment will be critically reviewed. …
Metadata
Title
0222. Major issues and their solutions in the management of HIV and TB — from the laboratory to the patient and population
Author
M Schechter
Publication date
01-12-2010
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1758-2652-13-S4-O23

Other articles of this Special Issue 4/2010

Journal of the International AIDS Society 4/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.